Do analysts recommend TLRY or BHC?

Tilray Brands currently has a consensus price target of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Bausch Health Companies 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Do analysts prefer TLRY or AUP?

Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media prefer TLRY or SLS?

In the previous week, Tilray Brands and Tilray Brands both had 1 articles in the media. Tilray Brands' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tilray Brands 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Solaris Resources 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend TLRY or CARA?

Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities research analysts clearly believe Tilray Brands is more favorable than Cara Operations. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tilray Brands 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Cara Operations 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, TLRY or CARA?

Cara Operations has lower revenue, but higher earnings than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tilray Brands C$858.28M 0.94 -C$183.24M -C$14.63 N/A Cara Operations N/A N/A N/A N/A N/A

Which has stronger valuation and earnings, CRON or TLRY?

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cronos Group C$159.54M 9.35 -C$32.78M N/A N/A Tilray Brands C$858.28M 0.94 -C$183.24M -C$14.63 N/A

Tilray Brands (TLRY) Competitors

C$6.52 -0.04 (-0.61%)

As of 07/3/2026 04:00 PM Eastern

Compare

TLRY vs. BHC, AUP, SLS, CARA, and CRON

Should you buy Tilray Brands stock or one of its competitors? MarketBeat compares Tilray Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tilray Brands include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Solaris Resources (SLS), Cara Operations (CARA), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry.

How does Tilray Brands compare to Bausch Health Companies?

Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

4.1% of Tilray Brands shares are held by institutional investors. Comparatively, 11.3% of Bausch Health Companies shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Comparatively, 11.3% of Bausch Health Companies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Bausch Health Companies is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A
Bausch Health Companies	C$10.53B	0.25	-C$125.65M	-C$3.24	N/A

Tilray Brands has a beta of 3.0845, suggesting that its share price is 208% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.942978, suggesting that its share price is 6% less volatile than the broader market.

Bausch Health Companies has a net margin of -13.54% compared to Tilray Brands' net margin of -158.75%. Bausch Health Companies' return on equity of 120.43% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Bausch Health Companies	-13.54%	120.43%	4.16%

Tilray Brands currently has a consensus price target of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Bausch Health Companies	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tilray Brands had 1 more articles in the media than Bausch Health Companies. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Bausch Health Companies. Tilray Brands' average media sentiment score of 0.00 equaled Bausch Health Companies'average media sentiment score.

Company	Overall Sentiment
Tilray Brands	Neutral
Bausch Health Companies	Neutral

Summary

Bausch Health Companies beats Tilray Brands on 8 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Tilray Brands (TSE:TLRY) and Aurinia Pharmaceuticals (TSE:AUP) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, institutional ownership, risk, analyst recommendations, media sentiment and profitability.

Tilray Brands currently has a consensus target price of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' stronger consensus rating and higher possible upside, analysts clearly believe Tilray Brands is more favorable than Aurinia Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aurinia Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Tilray Brands has higher revenue and earnings than Aurinia Pharmaceuticals. Tilray Brands is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A
Aurinia Pharmaceuticals	C$57.59M	0.00	-C$190.03M	-C$1.48	N/A

Aurinia Pharmaceuticals has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Aurinia Pharmaceuticals	N/A	N/A	N/A

4.1% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Tilray Brands had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Aurinia Pharmaceuticals. Tilray Brands' average media sentiment score of 0.00 equaled Aurinia Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Tilray Brands	Neutral
Aurinia Pharmaceuticals	Neutral

Summary

Tilray Brands beats Aurinia Pharmaceuticals on 8 of the 12 factors compared between the two stocks.

How does Tilray Brands compare to Solaris Resources?

Tilray Brands (TSE:TLRY) and Solaris Resources (TSE:SLS) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, media sentiment, institutional ownership, profitability and dividends.

4.1% of Tilray Brands shares are held by institutional investors. Comparatively, 16.4% of Solaris Resources shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Comparatively, 40.6% of Solaris Resources shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Tilray Brands and Tilray Brands both had 1 articles in the media. Tilray Brands' average media sentiment score of 0.00 equaled Solaris Resources'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Solaris Resources	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 103.99%. Solaris Resources has a consensus price target of C$19.50, suggesting a potential upside of 57.77%. Given Tilray Brands' higher possible upside, equities analysts clearly believe Tilray Brands is more favorable than Solaris Resources.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solaris Resources	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Solaris Resources has lower revenue, but higher earnings than Tilray Brands. Solaris Resources is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A
Solaris Resources	N/A	N/A	-C$46.49M	-C$0.19	N/A

Tilray Brands has a beta of 3.0845, meaning that its stock price is 208% more volatile than the broader market. Comparatively, Solaris Resources has a beta of 1.721408, meaning that its stock price is 72% more volatile than the broader market.

Solaris Resources has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Solaris Resources' return on equity of 60.97% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Solaris Resources	N/A	60.97%	-51.67%

Summary

Solaris Resources beats Tilray Brands on 8 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

In the previous week, Tilray Brands had 1 more articles in the media than Cara Operations. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Cara Operations. Tilray Brands' average media sentiment score of 0.00 equaled Cara Operations'average media sentiment score.

Company	Overall Sentiment
Tilray Brands	Neutral
Cara Operations	Neutral

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A
Cara Operations	N/A	N/A	N/A	N/A	N/A

Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 103.99%. Given Tilray Brands' stronger consensus rating and higher possible upside, equities research analysts clearly believe Tilray Brands is more favorable than Cara Operations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Cara Operations	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

4.1% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -158.75%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-158.75%	-88.06%	-1.41%
Cara Operations	N/A	N/A	N/A

Summary

Tilray Brands beats Cara Operations on 6 of the 9 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

4.5% of Cronos Group shares are owned by institutional investors. Comparatively, 4.1% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cronos Group currently has a consensus price target of C$4.75, indicating a potential upside of 19.05%. Tilray Brands has a consensus price target of C$13.30, indicating a potential upside of 103.99%. Given Tilray Brands' higher possible upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cronos Group	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tilray Brands	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Cronos Group has higher earnings, but lower revenue than Tilray Brands.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cronos Group	C$159.54M	9.35	-C$32.78M	N/A	N/A
Tilray Brands	C$858.28M	0.94	-C$183.24M	-C$14.63	N/A

Cronos Group has a net margin of -1.29% compared to Tilray Brands' net margin of -158.75%. Cronos Group's return on equity of -0.19% beat Tilray Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cronos Group	-1.29%	-0.19%	-3.73%
Tilray Brands	-158.75%	-88.06%	-1.41%

In the previous week, Tilray Brands had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.00 equaled Tilray Brands'average media sentiment score.

Company	Overall Sentiment
Cronos Group	Neutral
Tilray Brands	Neutral

Cronos Group has a beta of 1.134248, indicating that its share price is 13% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 3.0845, indicating that its share price is 208% more volatile than the broader market.

Summary

Cronos Group beats Tilray Brands on 8 of the 14 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TLRY vs. The Competition

Export

Metric	Tilray Brands	Drug Manufacturers Industry	Medical Sector	TSE Exchange
Market Cap	C$811.51M	C$6.60B	C$7.18B	C$13.07B
Dividend Yield	N/A	2.83%	2.67%	6.18%
P/E Ratio	-0.45	5.11	28.02	36.51
Price / Sales	0.94	1,653.39	534.82	10.34
Price / Cash	5.95	10.18	49.26	82.29
Price / Book	0.48	10.83	10.96	4.52
Net Income	-C$183.24M	C$20.27B	C$3.57B	C$299.09M
7 Day Performance	-0.61%	1.30%	2.12%	1.85%
1 Month Performance	-5.37%	-1.17%	5.25%	1.71%
1 Year Performance	-2.69%	9.82%	33.29%	36.40%

Tilray Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TLRY Tilray Brands	1.1232 of 5 stars	C$6.52 -0.6%	C$13.30 +104.0%	-2.7%	C$811.51M	C$858.28M	N/A	2,650
BHC Bausch Health Companies	0.2601 of 5 stars	C$7.10 +4.1%	N/A	-25.9%	C$2.65B	C$10.53B	N/A	19,900
AUP Aurinia Pharmaceuticals	N/A	N/A	N/A	N/A	C$2.15B	C$57.59M	N/A	300	High Trading Volume
SLS Solaris Resources	1.373 of 5 stars	C$11.22 -7.1%	C$19.50 +73.8%	+64.1%	C$1.87B	N/A	N/A	10	Gap Down
CARA Cara Operations	N/A	N/A	N/A	N/A	C$1.62B	N/A	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:TLRY) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Summary

How does Tilray Brands compare to Solaris Resources?

Summary

How does Tilray Brands compare to Cara Operations?

Summary

How does Tilray Brands compare to Cronos Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tilray Brands (TLRY) Competitors

TLRY vs. BHC, AUP, SLS, CARA, and CRON

How does Tilray Brands compare to Bausch Health Companies?

Do insiders & institutionals believe in TLRY or BHC?

Which has better earnings & valuation, TLRY or BHC?

Which has more volatility & risk, TLRY or BHC?

Is TLRY or BHC more profitable?

Do analysts recommend TLRY or BHC?

Does the media prefer TLRY or BHC?

Summary

How does Tilray Brands compare to Aurinia Pharmaceuticals?

Do analysts prefer TLRY or AUP?

Which has stronger valuation & earnings, TLRY or AUP?

Is TLRY or AUP more profitable?

Do insiders & institutionals hold more shares of TLRY or AUP?

Does the media prefer TLRY or AUP?

Summary

How does Tilray Brands compare to Solaris Resources?

Do insiders & institutionals believe in TLRY or SLS?

Does the media prefer TLRY or SLS?

Do analysts recommend TLRY or SLS?

Which has higher earnings & valuation, TLRY or SLS?

Which has more risk and volatility, TLRY or SLS?

Is TLRY or SLS more profitable?

Summary

How does Tilray Brands compare to Cara Operations?

Does the media refer more to TLRY or CARA?

Which has stronger earnings and valuation, TLRY or CARA?

Do analysts recommend TLRY or CARA?

Do institutionals & insiders believe in TLRY or CARA?

Is TLRY or CARA more profitable?

Summary

How does Tilray Brands compare to Cronos Group?

Do insiders and institutionals believe in CRON or TLRY?

Do analysts prefer CRON or TLRY?

Which has stronger valuation and earnings, CRON or TLRY?

Is CRON or TLRY more profitable?

Does the media favor CRON or TLRY?

Which has more risk and volatility, CRON or TLRY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TLRY vs. The Competition

Tilray Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools